エピソード

  • Episode 14: Diagnostic criteria for AD
    2024/12/12
    Dr. Nicolas Villain outlines why it is so important to consider both clinical symptoms and biological findings when diagnosing Alzheimer's disease.
    続きを読む 一部表示
    18 分
  • Episode 13: Advances in MASLD and MASH
    2024/08/14
    Prof. Vlad Ratziu discusses the updated subclassification and nomenclature for steatotic liver disease, the therapeutic advance of resmetirom, and the future for MASLD and MASH.
    続きを読む 一部表示
    37 分
  • Episode 12: Defining ARDS
    2024/07/05
    Prof. Giacomo Grasselli takes us through the new concepts and explains why defining ARDS is such a difficult proposition.
    続きを読む 一部表示
    16 分
  • Episode 11: Cardiac rehabilitation in patients with frailty
    2024/05/24
    Dr. Eduard Shantsila discusses rehabilitation approaches for complex patients with heart disease and comorbid frailty, including those with cognitive vulnerability.
    続きを読む 一部表示
    19 分
  • Episode 10: Disease-modifying therapy for type 1 diabetes
    2024/02/29
    Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.
    続きを読む 一部表示
    35 分
  • Episode 9: The gut microbiome and CAR T-cell therapy
    2024/02/14
    Prof. Marion Subklewe explores the interplay between the gut microbiota and the efficacy and safety of CAR T-cell therapy in people with hematologic malignancies.
    続きを読む 一部表示
    20 分
  • Episode 8: AI in stroke
    2024/01/03
    Prof. Susanne Wegener discusses her team’s work to develop deep learning models that outperform neurologists in predicting patients’ clinical outcomes after stroke.
    続きを読む 一部表示
    15 分
  • Episode 7: A deep dive into ADAURA
    2023/12/06
    A conversation with Dr. Luis Paz-Ares about the key questions raised by the ADAURA trial of adjuvant osimertinib in early-stage NSCLC.
    続きを読む 一部表示
    18 分